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Introduction
Systemic amyloidosis is a rare disease and it is caused 
by deposition of insoluble abnormal fibrillary proteins 
known as amyloid in extracellular space 1. Three different 
forms of amyloidosis can be distinguished, the primary 
(AL), secondary (AA) and family form. Localized amyloi-
dosis occurs in the pancreas in type 2 diabetic patients 
and in patients on chronic hemodialysis1–4. 
This is a disease of older adults and te median age at 
diagnosis is about 60 years.
The clinical presentation in amyloidosis depends on the 
affected organs and the symptoms are usually nonspecific. 
Case presentation
A  64 years old female presented to the University Hos-
pital with two month hystory of progressive dyspnea, 
weakness, fatigue loss of appetite and cough. The patient 
had a past medical history of heart failure with pericar-
dial and pleural effusion two months prior to presentation. 
The patient developed weakness, progresive dispnea and 
a cough. The cardiological outpatient diagnosis and treat-
ment indicated a progressive heart failure. MSCT and MR 
showed ascites and calcified lymph nodes in abdomen.
Myelogram was normal. Complete gastroenterology 
exam showed no signs of malignancy. Clinical condition 
of the patient was bad and despite all measures, paren-
teral  diet and suporting therapy patient died of cardiac 
failure and malnutrition.
Autopsy showed ascites, pleural and pericardial effu-
sion, pulmonary edema, dilated and increased heart, pan-
creas with fibrosis and cacification of the surrounding 
fatty tissue. Abdominal lymph nodes were enlarged and 
calcified. The small and large intestine were edematous. 
Histological examination showed amyloid deposits and 
thickening of the wall of the blood vessels in the myocard, 
thyroid gland, liver (Figure 1, 2 and 3), kidneys and lungs. 
Amyloid deposits were found in the wall of the submucosal 
blood vessels in the stomac, small and large intestine (Fig-
ure 4, 5 and 6). The pancreas was partialy preserved, par-
tialy necrotic. The surrounding adipose tissue was ne-
crotic with calcification and infiltrated by lymphocytes 
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A B S T R A C T
Systemic amyloidosis is a rare disease and it is caused by deposition of insoluble abnormal fibrillary proteins known 
as amyloid in extracellular space. Protein deposits are components of immunoglobulins produced by plasma cells and 
B–lymphocytes in response to antigenic stimulation. Three different forms of amyloidosis can be distinguished, the pri-
mary (AL), secondary (AA) and family form. Localized amyloidosis occurs in the pancreas in type 2 diabetic patients and 
in patients on chronic hemodialysis. The clinical presentation in amyloidosis depends on the affected organs. Symptoms 
are non-specific and included fatugue, weight loss, nephrotic syndrome, restrictive cardiomyopathy with thickening of the 
interventricular septum and ventricular wall, peripheral neuropathy, hepatomegaly, macroglossia, purpura and bleeding 
diathesis. In these article we presented the unexpected systemic amyloidosis in a patient with restrictive cardiomyopathy 
and without malignant and hematological diseases who suffered from dyspnea, weakness, fatigue loss of appetite and 
cough. Diagnosis of systemic amyloidosis was made upon histological samples after autopsy. 
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Discussion
Amyloidosis is rare disease with incidence of approxi-
mately 6–10 case per milion persons a year. It is character-
ized by the extracellular deposition of abnormal fibrillar 
protein, which disrupts tissue structure and function. 
There are six types of amyloidosis: primary, secondary, 
hemodialysis-related, hereditary, senile and localized1.  
The most commonly affected organs are the heart and 
kidneys while the GI tract is rarely affected, but this can 
occur in primary and secundary form of the amyloidosis. 
The amyloid deposits in the GI tract are associated with 
the diarrhea, anorexia, weight loss, nausea and vomiting, 
dyspepsia, hemorrhage, steatorrhea or constipation5,6.
Amyloid deposits in the stomach wall occur in less than 
10% of patients. Endoscopic examination may show thick-
ened gastric folds, gastric ulcers, hematomas, granular 
appering mucousa and plaque-like lesion. Histological 
examiation reveale amyloid deposition on the muscularis 
mucosa, submucosal vessels and muscularis propria in 
almost all areas of the gastric wall2–4.
Amyloid deposition in the GI tract is most prominent 
in the small intestine. Amyloid deposition is seen in the 
mucosa, the submucosal connective tissue, the muscularis 
mucosa, and muscularis propria, within nerves and most-
ly within blood vessel walls. With increased deposition, a 
variety of symptoms, such as bleeding, motility disorders, 
and malabsorption, may occur and deposition within blood 
vessel walls may lead to bowel ischemia, mucosal atrophy 
and ulceration, and eventually perforation2–6.
Amyloidosis of the large intestine must be differenti-
ated from inflammatory bowel disease, ischemic colitis, 
malignant diseases and collagenopathies. The descending 
and rectosigmoid colon are mostly involved. Endoscopic 
examination may show polipous lesions, ulceration and 
Fig. 1. Deposit of the amorphous eosinophilic material in wall 
of the heart blood vessels. HE 40x.
Fig. 2. Deposit of the amorphous eosinophilic material in wall 
of the thyroid gland blood vessels. HE 40x.
Fig. 3. Deposit of the amorphous eosinophilic material in wall 
of the liver blood vessels. HE 40x.
Fig. 4. Deposit of the amorphous eosinophilic material in wall 
of the stomac submucosal blood vessels. HE 40x.
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petechial lesions. The symptoms include motality disor-
ders or pseudoobstruction, acute obstruction, rectal bleed-
ing and colonic diltaton2,7.
In autopsy series, 56–95% of patients with amyloidosis 
had liver involvement.  Clinical manifestations of hepatic 
amyloidosis are usually mild and included hepatomegaly 
with elevated alkalinephosphatase level, ascites which is 
often due to cardiac failure and hypoalbuminemia and 
hyperbilirubinemia. Disposal of amyloid is periportal, 
leads to atrophy of hepatocytes, and when blocking sinu-
soids, portal hypertension occurs. The safety of liver biop-
sies is controversial and bleeding is the most common 
complication.8
Cardiac amyloidosis is characterized by amyloid depos-
its in the ventricles and atria, perivascularly, as well as in 
the conductive system. The heart amyloidosis leads to in-
filtrative / restrictive cardiomyopathy. Amyloidosis of the 
heart often coexists with significant dysfunction of other 
major organs and the presence of cardiac amyloidosis is 
often the worst prognostic factor9,10.
Conclusion
In this article we presented the case of a patient who 
has been treated for a number of months by progressive 
heart failure and with non-specific symptoms by the GI 
tract. Clinical examination did not detect the cause of heart 
failure and progressive loss of weight and malnutrition. 
The patient died because of the multi-organ failure. The 
diagnosis of systemic amyloidosis was performed by exam-
ining samples obtained during autopsy. Systemic amyloi-
dosis should be considered in patients with cardiomyopathy, 
proteinuria, hepatomegaly, and different and non-specific 
symptoms of GI tracts without specific endoscopic findings. 
Fig. 5. Deposit of the amorphous eosinophilic material in wall 
of the small intestine submucosal blood vessels. HE 40x.
Fig. 6. Deposit of the amorphous eosinophilic material in wall 
of the large intestine submucosal blood vessels. HE 40x.
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NEOČEKIVANA SISTEMSKA AMILOIDOZA KOD BOLESNICE S RESTRIKTIVNOM 
KARDIOMIOPATIJOM:
S A Ž E T A K
Sistemska amiloidoza je rijetka bolest koju uzrokuje taloženje netopivih abnormalnih fibrilarnih proteina poznatih 
kao amiloid u izvanstaničnom prostoru. Proteinske naslage su komponente imunoglobulina koje proizvode plazmastan-
ice i B-limfociti kao odgovor na antigensku stimulaciju. Razlikujemo tri osnovna oblika amiloidoze, primarni (AL), 
sekundarni (AA) i obiteljski oblik. Lokalizirani oblik amiloidoze javlja se u gušterači kod bolesnika s dijabetesom tipa 2 
i kod pacijenata s kroničnom hemodijalizom. Klinička slika amiloidoze ovisi o zahvaćenim organima. Simptomi su 
nespecifični i uključuju umor, gubitak težine, nefrotski sindrom, restriktivnu kardiomiopatiju sa zadebljanjem interven-
trikularnog septuma i stjenke lijeve klijetke, periferne neuropatije, hepatomegaliju, makroglosiju, purpuru i dijatezu. U 
ovom radu prikazali smo neočekivani nalaz sistemske amiloidoze kod pacijentice s restriktivnom kardiomiopatijom i 
dispnejom, gubitkom apetita, kašljem i izraženom slabošću ali bez znakova malignih i hematoloških bolesti. Dijagnoza 
sistemske amiloidoze postavljena je na histološkim uzorcima nakon obdukcije.
